NCT06417593

Brief Summary

Isolation and identification of Pseudomonas aeruginosa using basic microbiological methods, such as Gram staining, cultivation on cetrimide agar and biochemical reactions from Samples from patients with different types of health care associated infections as urinary tract infections, infected burn, ventilator associated pneumonia, blood stream infections and surgical site infections that will be obtained under complete aseptic precautions.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 11, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 16, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

May 20, 2024

Status Verified

May 1, 2024

Enrollment Period

7 months

First QC Date

May 11, 2024

Last Update Submit

May 16, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Isolation and identification of pseudomonas aeruginosa causing different nosocomial infections.

    Isolation and identification of Pseudomonas aeruginosa using basic microbiological methods, such as Gram staining, cultivation on cetrimide agar and biochemical reactions

    6 months

  • Identification of antibiotic susceptibility pattern of isolated strains of pseudomonas

    Antibiotic susceptibility testing of the isolates will be performed using disc diffusion method according to clinical laboratory standards institute (CLSI) guidelines

    6 months

  • Detection of biofilm forming isolates

    Detection of biofilm forming isolates by tissue culture plate method.

    6 months

  • Detection of virulence and antibiotic resistance genes of pseudomonas aeruginosa.

    Detection of virulence and antibiotic resistance genes by conventional Polymerase Chain Reaction

    6 months

Study Arms (1)

group1

Pseudomonas Aeruginosa Isolates

Eligibility Criteria

Age1 Year - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Samples from patients with different types of health care associated infections as urinary tract infections, infected burn, ventilator associated pneumonia, blood stream infections and surgical site infections will be obtained under complete aseptic precautions.

You may qualify if:

  • Samples from patients with different types of health care associated infections as urinary tract infections, infected burn, ventilator associated pneumonia, blood stream infections and surgical site infections will be obtained under complete aseptic precautions.

You may not qualify if:

  • Any infection before 48 hours of patient admission at Hospital

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of medicine Sohag university hospital

Sohag, Egypt

RECRUITING

MeSH Terms

Conditions

Pseudomonas Infections

Condition Hierarchy (Ancestors)

Gram-Negative Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfections

Central Study Contacts

Martina Gamil Fayez, Demonstrator at Microbiology

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator

Study Record Dates

First Submitted

May 11, 2024

First Posted

May 16, 2024

Study Start

April 1, 2024

Primary Completion

November 1, 2024

Study Completion

March 1, 2025

Last Updated

May 20, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL

Locations